-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 14, Bihuan Pharmaceutical announced that the company had recently received the "Approval Notice for Supplementary Application for Doxycycline Hydrochloride Tablets" approved and issued by the State Food and Drug Administration.
Doxycycline hydrochloride belongs to the tetracycline class of antibiotics and is a broad-spectrum bacteriostatic agent
The PDB drug comprehensive database shows that the sales of terminal doxycycline hydrochloride tablet samples in Chinese public medical institutions will be 2.
After querying the Yaozhi.
Up to now, the company's R&D investment in the consistency evaluation of doxycycline hydrochloride tablets is approximately RMB 10,564,700 (unaudited)